Global Neuromodulation Market Research Report 2018

Global Neuromodulation market is set to surpass US$ 7 Billion by 2025.
With such an extensive therapeutic scope, and immense ongoing enhancements in biotechnology, neuromodulation will likely be a leading growth industry over the forecast period. The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, ageing population, technological advances and deal making activity globally.
The report titled “Global Neuromodulation Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the Global Neuromodulation Market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as application, technology, geography, company and competitive landscape. A comprehensive analysis has been done on market share of all the categories. Key trends in terms of merger & acquisitions, collaborations, partnerships and agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the Neuromodulation market.
The report concludes with the profiles of major players in the Neuromodulation market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the Neuromodulation market.
Further key findings from the report suggest:
• North America is the most attractive market in the neuromodulation market
• Chronic pain is the major application segment of the neuromodulation market
• With regard to technology, spinal cord stimulation represents the largest segment of the neuromodulation market
• The APAC marketplace is slated to grow at the highest rate, and China, India and Japan will be major igniters
Market Segmentation: Global Neuromodulation Market
The global neuromodulation market has been segmented on the basis of technology, application, geography and company
Neuromodulation Market, by Technology
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation (VNS)
• Other Technologies
Neuromodulation Market, by Application
 
• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression (TRD)
• Obsessive Compulsive Disorder (OCD)
• Other Applications
Neuromodulation Market, by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)
Neuromodulation Market, by Company
• Medtronic
• Boston Scientific
• St. Jude Medical (Abbott)
• Liva Nova
• Nevro
• Other Companies

Diabetes Insulin Delivery Pens Market Research Report 2018

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025.
Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices.
 
“Diabetes Insulin Delivery Pens Market Research Report 2018” presents an in-depth assessment of the diabetes insulin delivery pen market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for diabetes insulin delivery pen market. The report includes historic data from 2011 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025.It also provides an all-round analysis of overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on market share of diabetes insulin delivery pen segment and countries-based market. The report also explores detailed description of growth drivers and inhibitors of the diabetes insulin delivery pens market.
The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2011 to 2017 and forecasts to 2025.
The report concludes with the profiles of major players in the diabetes insulin delivery pens market. The key market players are evaluated on various parameters such as company overview, product portfolios and recent development of the diabetes insulin delivery pens market.
Market segment by Type, the product can be split into
• Reusable Insulin Pens
• Disposable Insulin Pens
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Major Countries Analyzed Under This Report are:
United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major markets(10MM) 2011-2025
• Insulin Users Insights in 10 major markets(10MM) 2011 – 2025
• Total Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025
• Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025
• Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025
• Total Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025
• Diabetes Insulin Delivery Pen Market, By Geography (Volume and Value),2011 – 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
  and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development
1. Executive Summary
 
2. Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025
2.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025
2.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025
3. Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025
3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025
3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025
4. Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025
4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025
4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025
5. Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025
5.1 DiabtesReusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025
5.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025
6. Key Market Drivers & Inhibitors of the Diabetes Insulin Delivery Pen Market
6.1 Market Drivers
6.2 Market Inhibitors
7. Diabetes Insulin Delivery Pen Market & Forecast (2011 – 2025) – Geographical Landscape
7.1 United States
7.1.1 Overall Diabetes Population & Forecast (Volume)
7.1.2 Insulin Users & Forecast (Volume)
7.1.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.1.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users(Volume)
7.1.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users (Volume)
7.1.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.1.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast(Value)
7.1.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.2 Germany
7.2.1 Overall Diabetes Population & Forecast (Volume)
7.2.2 Insulin Users & Forecast (Volume)
7.2.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.2.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.2.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.2.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.2.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.2.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.3 France
7.3.1 Overall Diabetes Population & Forecast (Volume)
7.3.2 Insulin Users & Forecast (Volume)
7.3.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.3.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.3.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.3.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.3.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.3.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.4 Italy
7.4.1 Overall Diabetes Population & Forecast (Volume)
7.4.2 Insulin Users & Forecast (Volume)
7.4.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.4.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.4.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.4.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.4.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.4.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.5 Spain
7.5.1 Overall Diabetes Population & Forecast (Volume)
7.5.2 Insulin Users & Forecast (Volume)
7.5.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.5.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.5.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.5.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.5.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.5.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.6 United Kingdom
7.6.1 Overall Diabetes Population & Forecast (Volume)
7.6.2 Insulin Users & Forecast (Volume)
7.6.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.6.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.6.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.6.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.6.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.6.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.7 Japan
7.7.1 Overall Diabetes Population & Forecast (Volume)
7.7.2 Insulin Users & Forecast (Volume)
7.7.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.7.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.7.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.7.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.7.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.7.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.8 China
7.8.1 Overall Diabetes Population & Forecast (Volume)
7.8.2 Insulin Users & Forecast (Volume)
7.8.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.8.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.8.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.8.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.8.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.8.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.9 India
7.9.1 Overall Diabetes Population & Forecast (Volume)
7.9.2 Insulin Users & Forecast (Volume)
7.9.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.9.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.9.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.9.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.9.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.9.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
7.10 Brazil
7.10.1 Overall Diabetes Population & Forecast (Volume)
7.10.2 Insulin Users & Forecast (Volume)
7.10.3 Overall Diabetes Insulin Delivery Pen Users & Forecast (Volume)
7.10.3.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Users & Forecast (Volume)
7.10.3.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Users & Forecast (Volume)
7.10.4 Overall Diabetes Insulin Delivery Pen Market & Forecast (Value)
7.10.4.1 Diabetes Reusable (Cartridge) Insulin Delivery Pen Market & Forecast (Value)
7.10.4.2 Diabetes Prefilled (Disposable) Insulin Delivery Pen Market & Forecast (Value)
8. Key Companies Analysis
8.1 Novo Nordisk
8.1.1 Business Overview
8.1.2 Insulin Pen Products Portfolio
8.1.3 Recent Development
8.2 Eli Lilly
8.2.1 Business Overview
8.2.2 Insulin Pen Products Portfolio
8.2.3 Recent Development
8.3 Sanofi
8.3.1 Business Overview
8.3.2 Insulin Pen Products Portfolio
8.4 Owen Mumford
8.4.1 Business Overview
8.4.2 Insulin Pen Products Portfolio
8.5 Ypsomed
8.5.1 Business Overview
8.5.2 Insulin Pen Products Portfolio
8.5.3 Recent Development
8.6 Biocon Ltd. 
8.6.1 Business Overview
8.6.2 Insulin Pen Products Portfolio

Specialist Medical and Social Recruiters – PHC Solutions

If you are looking for locum work, then look no further we’re sure to have the ideal placement for you. If a reliable locum is what you require, by choosing you have made the right choice. Purely Health Care Recruitment Consultants (PHC) is a London based agency. We provide retail pharmacy locums/clients with nationwide cover:

  • Using experienced consultants
  • Large databases with reliable locums
  • Daily, weekly, monthly and even long term placements
  • A service with the simplest of procedures
  • Our policy is to provide a fast & reliable no nonsense service
  • Placements for locums are available all year round
  • Clients will usually receive confirmations within
  • 48 hours of placing the booking

Fed up of agencies letting you down?

Call PHC Solutions for an honest and efficient service you can rely on

  • Free registration
  • Salary paid weekly
  • Transport & accommodation arranged and paid for
  • Short/long term bookings & permanent placements
  • Work available from a wide variety of clients
  • Referral bonus of £250 once referred locum completes 65 bookings24 hr weekend services via our on call consultant.
  • FREE REGISTRATION
  • Competitive rates
  • Large locum database
  • Nationwide cover

We supply a high caliber of locum pharmacist in terms of attendance, punctuality and professional ability. We endeavor to cover all bookings given to us and also try to cover all emergencies that may arise24 hr weekend service via our on call consultant. The consultants are highly experienced in this field and will always be available for any questions or queries that you may have. Click here for recent Healthcare Jobs in Birmingham

For further information please contact: TEL: 0121 623 7231 OR E-Mail Info@phcar.co.uk.